tiprankstipranks
Trending News
More News >
Microchip Technology (MCHP)
NASDAQ:MCHP

Microchip (MCHP) AI Stock Analysis

Compare
4,149 Followers

Top Page

MCHP

Microchip

(NASDAQ:MCHP)

Select Model
Select Model
Select Model
Neutral 58 (OpenAI - 5.2)
Rating:58Neutral
Price Target:
$77.00
▲(2.03% Upside)
Action:ReiteratedDate:02/12/26
The score is held back primarily by weakened GAAP profitability (TTM loss and margin compression) despite solid free cash flow and manageable—though still meaningful—leverage. Offsetting that, the latest earnings call points to a tangible recovery with strong revenue and non-GAAP margin/EPS guidance, while technicals show a medium-term uptrend but neutral near-term momentum. Valuation is constrained by the negative P/E, partially balanced by a ~2.45% dividend yield.
Positive Factors
Resilient free cash flow
Sustained positive and growing free cash flow is a durable strength: it funds debt paydown, dividends and targeted R&D/capex without relying on equity, improving financial flexibility as earnings recover and supporting multi-quarter deleveraging and strategic investments.
Strong design-win and product momentum
Meaningful design wins and automotive/data-center collaborations underpin durable revenue visibility; wins with OEMs and hyperscalers expand high-value content per system and create multi-year revenue streams as customers migrate to new standards and nodes.
High non‑GAAP gross margins and margin recovery guidance
Elevated gross margins driven by product mix and foundry-produced, high-margin products support sustainable operating leverage. Management’s guided margin recovery implies structural improvement in profitability as capacity/utilization normalize and higher-margin products scale.
Negative Factors
Elevated leverage
Material leverage at current earnings levels limits flexibility: servicing debt requires consistent cash generation and margin recovery. Elevated net debt/EBITDA constrains buybacks, forces prioritization of debt repayment over growth investments, and raises refinancing risk if earnings slip.
Deteriorated GAAP profitability
A move to TTM GAAP losses and sharply compressed operating margins erodes return on capital and stresses the economics of the business. Persistent GAAP weakness increases dependence on non‑GAAP adjustments and makes sustained dividend or investment increases riskier absent a clear earnings rebound.
High inventory & underutilization charges; supply limits
Large inventory days, fresh reserves and capacity underutilization charges reduce near-term margins and indicate demand/mix and fab-utilization mismatches. Multi-year fab ramp and substrate/foundry constraints could limit fulfillment and margin expansion as the company scales higher‑margin products.

Microchip (MCHP) vs. SPDR S&P 500 ETF (SPY)

Microchip Business Overview & Revenue Model

Company DescriptionMicrochip Technology Incorporated develops, manufactures, and sells smart, connected, and secure embedded control solutions in the Americas, Europe, and Asia. The company offers general purpose 8-bit, 16-bit, and 32-bit microcontrollers; 32-bit embedded microprocessors markets; and specialized microcontrollers for automotive, industrial, computing, communications, lighting, power supplies, motor control, human machine interface, security, wired connectivity, and wireless connectivity applications. It also provides development tools that enable system designers to program microcontroller and microprocessor products for specific applications; field-programmable gate array (FPGA) products; and analog, interface, mixed signal, and timing products comprising power management, linear, mixed-signal, high-voltage, thermal management, discrete diodes and metal oxide semiconductor field effect transistors (MOSFETS), radio frequency (RF), drivers, safety, security, timing, USB, Ethernet, wireless, and other interface products. In addition, the company offers memory products consisting of serial electrically erasable programmable read-only memory, serial flash memories, parallel flash memories, serial static random access memories, and serial electrically erasable random access memories for the production of very small footprint devices; and licenses its SuperFlash embedded flash and NVM technologies to foundries, integrated device manufacturers, and design partners for use in the manufacture of microcontroller products, gate array, RF, analog, and neuromorphic compute products that require embedded non-volatile memory, as well as provides engineering services. Further, it offers wafer foundry and assembly, and test subcontracting manufacturing services; and timing systems products, application specific integrated circuits, and aerospace products. Microchip Technology Incorporated was incorporated in 1989 and is headquartered in Chandler, Arizona.
How the Company Makes MoneyMicrochip generates revenue primarily through the sale of its semiconductor products, including microcontrollers, analog devices, and memory products. The company operates on a business-to-business model, selling to original equipment manufacturers (OEMs) and other industrial clients. Key revenue streams include direct sales from product lines, royalties from licensing its technology, and service agreements that provide ongoing support and development for clients. Additionally, Microchip has formed significant partnerships and collaborations with technology leaders and industry players, enhancing its market reach and driving sales through joint product offerings and integrated solutions. The company's focus on research and development also allows it to innovate continuously, meeting the evolving demands of its customer base, which further contributes to its earnings.

Microchip Key Performance Indicators (KPIs)

Any
Any
Revenue by Segment
Revenue by Segment
Examines sales performance across various business segments, shedding light on which areas are contributing most to overall growth.
Chart InsightsMicrochip's Semiconductor Products segment has faced a significant revenue decline since late 2023, likely due to inventory write-offs and underutilization charges impacting margins. However, the latest earnings call highlights a strong sequential recovery in net sales and improved margins, driven by robust bookings and strategic inventory reductions. Technology Licensing, while volatile, shows signs of recovery in 2025. Despite challenges in the automotive market and extended lead times, Microchip's positive guidance and progress in aerospace and defense suggest potential for a rebound.
Data provided by:The Fly

Microchip Earnings Call Summary

Earnings Call Date:Feb 05, 2026
(Q3-2026)
|
% Change Since: |
Next Earnings Date:May 11, 2026
Earnings Call Sentiment Positive
The call presents a constructive operational and financial recovery: revenue and backlog strengthened materially (Q3 net sales +4% sequential, +15.6% YoY; March guidance +6.2% sequential), non-GAAP margins and free cash flow improved, and the company announced meaningful design wins and strategic partnerships (Hyundai, Gen6 PCIe wins). However, noteworthy near-term headwinds remain — inventory days are high, meaningful inventory reserves and underutilization charges continue, leverage is still elevated (net debt/EBITDA 4.18) and certain supply-chain/foundry constraints are broadening. Management is prioritizing debt reduction and cautious OpEx discipline while investing to support growth. On balance, the positive execution, improving demand and strong guidance outweigh the operational and balance-sheet challenges.
Q3-2026 Updates
Positive Updates
Revenue Growth and Guidance Beat
Net sales for December were $1.186 billion, up 4% sequentially and 15.6% year-over-year, and above the high end of prior guidance. Guidance for March is $1.26 billion ± $20 million (midpoint +6.2% sequential, +29.8% YoY). Book-to-bill in December was well above 1 and backlog entering March materially higher than entering December.
Strong Non-GAAP Profitability
Non-GAAP gross margin reached 60.5% (up 379 basis points sequentially). Non-GAAP operating margin was 28.5% (up 418 basis points sequentially and up 800 basis points YoY). Non-GAAP net income was $252.8 million and non-GAAP diluted EPS was $0.44, $0.04 above the high end of original guidance. March non-GAAP EPS guidance: $0.48–$0.52.
Cash Flow and Adjusted Free Cash Flow
Cash flow from operations was $341.4 million and adjusted free cash flow was $305.6 million in December. Adjusted EBITDA for the quarter was $402 million (33.9% of net sales) and trailing twelve-month adjusted EBITDA was $1.23 billion.
Inventory and Distribution Improvements
Ending inventory was $1.058 billion, down $37.6 million sequentially; distributor inventory was 28 days (in normal range). The distributor sell-in vs sell-through gap shrank from $52.9 million in September to $11.7 million in December, indicating correction in distribution channels.
Design Wins and Product Momentum (Connectivity & Data Center)
Strategic collaboration announced with Hyundai Motor Group for 10BASE-T1S automotive Ethernet. Company reported three Gen6 PCIe switch design wins (one win expected to deliver $100M+ revenue in calendar 2027). Stated leadership claims for Gen6 PCIe (3nm) sampling with hyperscalers and strong momentum in automotive and industrial Ethernet (T1S, ASA).
Operational Discipline on CapEx and Leverage Trajectory
Capital expenditures were $22.5 million in the quarter and company expects FY2026 capex at or below $100 million. Net debt to adjusted EBITDA improved to 4.18 from 4.69 sequentially, and management plans to prioritize debt reduction using excess free cash flow above dividends.
Broad-Based End-Market Recovery
Management reported recovering demand across automotive, industrial, communications, data center, aerospace & defense, and consumer end markets; strongest performance in aerospace & defense and networking/data center solutions.
Improving Factory & Margin Outlook
Management expects inventory reserve charges to normalize and gross margins to stay elevated (guidance 60.5%–61.5% for March). Company reiterated long-term gross margin target (~65%) and cited product mix (high-margin foundry-produced products) and gradual fab ramp as drivers of further margin improvement.
Negative Updates
Inventory Reserve and Underutilization Charges
December included $58.4 million of new inventory reserves and $51.7 million of capacity underutilization charges (non-GAAP basis). Management indicated underutilization charges will persist and may take years to fully normalize, representing a multi-quarter headwind to gross margin.
Significant GAAP Adjustments and Low GAAP Earnings
On a GAAP basis, operating expenses included $107.6 million of acquisition intangible amortization, $62.1 million of share-based compensation, and $4.8 million of special charges (primarily Fab 2 closure). GAAP net income attributable to common shareholders was $34.9 million, or $0.06 per share — materially below non-GAAP results.
High Overall Inventory Days
Total inventory represented 201 days at quarter end, including 17 days of long life-cycle, high-margin products whose manufacturing capacity has been end-of-lifed by supply partners — a potential risk to future margins and fulfillment if capacity or sourcing issues persist.
Leverage Remains Elevated
Although net debt to adjusted EBITDA improved to 4.18 from 4.69, leverage remains elevated. Management emphasized being 'spooked' by the prior cycle and intends to prioritize debt reduction and maintain dividends while pausing buybacks until leverage declines meaningfully.
Supply-Chain and Foundry/Substrate Constraints
Management reported growing challenges on certain substrates, subcontracting capacity, and advanced-node foundry constraints. Lead times have begun to increase on some products and customer expedite requests have risen significantly, which could constrain near-term fulfillment and margin expansion.
Licensing and Other Revenue Lumpiness
December benefited from an uplift in 'other' revenue (licenses, FPGA, memory, timing), including one-time licensing-related benefits that are not expected to fully repeat in March, creating some lumpiness in quarter-to-quarter gross margin and revenue comparisons.
Company Guidance
Microchip guided March quarter net sales of $1.26 billion ± $20 million (midpoint +6.2% sequential, +29.8% year‑over‑year), with non‑GAAP gross margin of 60.5%–61.5%, non‑GAAP operating expenses 31.3%–31.7% of sales, non‑GAAP operating profit 28.8%–30.2% of sales, and non‑GAAP diluted EPS of $0.48–$0.52. For fiscal 2026 they expect a non‑GAAP cash tax rate of about 10% and capital expenditures at or below $100 million, and they plan to use excess free cash flow above dividends to pay down debt (December adjusted free cash flow $305.6M; cash & investments $250.7M; total debt down $12.1M q/q; net debt down $26M q/q; net debt/adjusted EBITDA 4.18 vs. 4.69; trailing‑12‑month adjusted EBITDA $1.23B). Management noted inventory reserves should largely normalize in March (December inventory $1.058B, 201 days; distributors 28 days) while capacity underutilization charges ($51.7M in December) will decline only modestly as fabs ramp over a multi‑year period.

Microchip Financial Statement Overview

Summary
Financials show a clear down-cycle: the income statement is the main drag (TTM net loss and sharply compressed EBIT margin despite ~50% gross margin). Offsetting that, the balance sheet is moderately leveraged (debt-to-equity ~0.81) and cash flow remains resilient with solid positive and growing free cash flow (~$820M TTM), supporting flexibility while earnings recover.
Income Statement
34
Negative
Profitability has deteriorated meaningfully. In TTM (Trailing-Twelve-Months), revenue is up modestly (+3.8%), but net income is negative (net margin about -4.4%) and operating profitability is very thin (EBIT margin ~1.2%), well below prior years. The company still maintains a solid gross margin (~50%), but the sharp drop from FY2023–FY2024 levels and the move from strong profits in FY2022–FY2024 to losses in TTM point to significant margin compression and a weaker earnings profile.
Balance Sheet
60
Neutral
Leverage looks manageable but not light for the current earnings level. In TTM (Trailing-Twelve-Months), debt is about $5.37B against equity of ~$6.56B (debt-to-equity ~0.81), an improvement versus earlier years when leverage was higher. However, returns have turned negative in TTM (negative return on equity), indicating the balance sheet is being supported by past profitability while current-period earnings are under pressure—raising the importance of an earnings rebound to keep leverage comfortably serviced.
Cash Flow
63
Positive
Cash generation remains a relative strength despite weaker earnings. In TTM (Trailing-Twelve-Months), operating cash flow is ~$911M and free cash flow is ~$820M, with free cash flow growing ~8.7% versus the prior period, signaling resilient cash conversion. The main weakness is that operating cash flow coverage is below 1x in recent periods, consistent with reduced cash generation compared with the strong FY2022–FY2024 cycle, but overall free cash flow remains solidly positive and supportive of financial flexibility.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue4.37B4.40B7.63B8.44B6.82B5.44B
Gross Profit2.25B2.47B5.00B5.70B4.45B3.38B
EBITDA887.00M1.04B3.44B4.10B2.87B1.83B
Net Income-96.60M-500.00K1.91B2.24B1.29B349.40M
Balance Sheet
Total Assets14.33B15.37B15.87B16.37B16.20B16.48B
Cash, Cash Equivalents and Short-Term Investments250.70M771.70M319.70M234.00M319.40M282.00M
Total Debt5.40B5.67B6.03B6.60B7.85B9.07B
Total Liabilities7.77B8.30B9.22B9.86B10.30B11.14B
Stockholders Equity6.56B7.08B6.66B6.51B5.89B5.34B
Cash Flow
Free Cash Flow819.90M772.10M2.61B3.13B2.47B1.82B
Operating Cash Flow911.00M898.10M2.89B3.62B2.84B1.92B
Investing Cash Flow-199.40M-287.80M-392.10M-599.50M-477.70M-173.30M
Financing Cash Flow-1.05B-158.30M-2.41B-3.10B-2.33B-1.86B

Microchip Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price75.47
Price Trends
50DMA
72.63
Positive
100DMA
66.29
Positive
200DMA
65.69
Positive
Market Momentum
MACD
1.04
Positive
RSI
49.47
Neutral
STOCH
16.32
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MCHP, the sentiment is Neutral. The current price of 75.47 is below the 20-day moving average (MA) of 77.26, above the 50-day MA of 72.63, and above the 200-day MA of 65.69, indicating a neutral trend. The MACD of 1.04 indicates Positive momentum. The RSI at 49.47 is Neutral, neither overbought nor oversold. The STOCH value of 16.32 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for MCHP.

Microchip Risk Analysis

Microchip disclosed 46 risk factors in its most recent earnings report. Microchip reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Microchip Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
$58.14B95.1917.94%0.62%30.48%339.29%
67
Neutral
$59.29B29.3421.01%1.79%-6.81%-23.16%
64
Neutral
$27.59B208.751.47%-16.13%-81.06%
64
Neutral
$9.01B23.036.49%4.37%-2.18%-16.84%
64
Neutral
$30.40B178.650.93%1.28%-17.33%-76.71%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
58
Neutral
$41.09B-1.09%2.79%-23.36%-131.15%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MCHP
Microchip
75.47
20.01
36.08%
MPWR
Monolithic Power
1,231.95
626.57
103.50%
NXPI
NXP Semiconductors
235.07
22.20
10.43%
ON
ON Semiconductor
69.68
22.30
47.07%
SWKS
Skyworks Solutions
59.82
-1.62
-2.64%
STM
STMicroelectronics
34.56
10.38
42.91%

Microchip Corporate Events

Business Operations and StrategyPrivate Placements and Financing
Microchip Issues Convertible Notes to Optimize Capital Structure
Positive
Feb 11, 2026

On February 9–11, 2026, Microchip Technology issued $900 million of 0% Convertible Senior Notes due 2030 in a private Rule 144A placement, generating net proceeds of about $883.3 million after fees. The notes, which are senior unsecured obligations with an initial conversion price of roughly $104.17 per share, were sold to qualified institutional buyers, with Microchip retaining the option to settle conversions in cash, stock or a mix.

The company used approximately $68 million of the proceeds to purchase capped call transactions with dealers, setting an initial cap at $148.82 per share to mitigate dilution and potential cash outlays upon conversion. Microchip plans to apply the remaining funds to repay borrowings under its commercial paper program, effectively terming out short‑term debt and fine‑tuning its capital structure while managing future equity dilution for existing shareholders.

The most recent analyst rating on (MCHP) stock is a Hold with a $69.00 price target. To see the full list of analyst forecasts on Microchip stock, see the MCHP Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 12, 2026